LYRA
Lyra Therapeutics, Inc. Common Stock
$2.26
0.00%
0.00
Notify me if price changes either direction
Buy LYRA stocks now with Interactive Brokers – the most advanced investment platform
Contents
- Performance
- Key stats
- Financials
- US politician trades
Loading
Key Stats
Market cap.
4.0M
Enterprise value
13.5M
Trailing PE
-0.031468531468531
Forward PE
-2.3636363
PEG Ratio
0.00050394445412239
Enterprise to EBITDA
-0.423
Enterprise to revenue
22.462
Price to book MRQ
-0.91903454251386
Price to sales TTM
6.9220386
Financials
Fiscal Year Ends
2024-12-31
Most Recent Quarter (MRQ)
2025-09-30
Revenue (TTM)
600.0K
EBITDA
-31898000
Diluted EPS TTM
-22.9
Total Cash (MRQ)
22.1M
Current ratio (MRQ)
2.428
Operating Cash Flow (TTM)
-34145000
LYRA trades by the US politicians
Percentage
0%
0 sells
100%
0 buys
Amount
$0
0 sells
$0
0 buys
In the last 0 months
January 2026
| Senator | Action | Amount | Date | Owner | Type |
|---|---|---|---|---|---|
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
There are no signals yet
Keep up to date with our realtime buy and sell alerts, exclusive insights, and in-depth analysis.
